The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
ketamine is what's called an nmda receptor blocker now when I say blocker I'm not getting into the details of what specific form of blocker it is but I do want to mention that a blocker is sometimes referred to as an antagonist whereas something that promotes the activity of a receptor is called an Agonist okay so if you can just remember that ketamine is an nmda receptor antagonist or blocker then you should be fine for the rest of today's conversation
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.